Cupertino, CA, United States of America

Elbert D Chen

This inventor holds 53 USPTO granted patents and 15 published patent applications and 5 EPO patents, primarily in User Interface Design. Top assignee: Apple Inc.. Active years: 2012-2026.

USPTO Granted Patents = 53 

% Patents Active = 98.1

 

Average Co-Inventor Count = 6.1

ph-index = 13

Forward Citations = 1,022(Granted Patents)

Forward Citations (Not Self Cited) = 855(Dec 10, 2025)


Company Filing History:


Years Active: 2012-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
User Interface
Character Recognition
Media Navigation
Podcast Applications
Input Device
Graphical User Interface
Broadcast Control
Application Menu
User Detection
Interactive Interface
Music Playback
Visual Output
53 patents (USPTO):Explore Patents

Title: Inventor Elbert D Chen - Revolutionizing Biotechnology

Introduction: Elbert D Chen, a distinguished inventor hailing from Cupertino, CA, has made significant contributions to the field of biotechnology through his innovative creations and groundbreaking research.

Latest Patents: Elbert D Chen's latest patents focus on novel methods for genetic engineering, including advanced CRISPR technologies for precise gene editing and innovative approaches for synthetic biology applications.

Career Highlights: With a career spanning over two decades, Elbert D Chen has held key positions in renowned biotech companies and research institutions, leading pioneering projects that have pushed the boundaries of biotechnological advancements.

Collaborations: Elbert D Chen has collaborated with leading scientists, researchers, and biotech experts from around the globe, fostering a culture of innovation and knowledge exchange to drive forward progress in the field of biotechnology.

Conclusion: Elbert D Chen's relentless passion for innovation and his unwavering commitment to advancing biotechnology have solidified his position as a trailblazer in the industry, inspiring future generations of inventors and researchers to push the boundaries of what is possible in the realm of biotechnological innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…